Literature DB >> 20195487

Chain-breaking antioxidant activity of reduced forms of mitochondria-targeted quinones, a novel type of geroprotectors.

Vitaly A Roginsky1, Vadim N Tashlitsky, Vladimir P Skulachev.   

Abstract

The chain-breaking antioxidant activities of reduced form of novel type of geroprotectors, mitochondria-targeted quinones (QH(2)) have quantitatively been measured for the first time. To this end, the chain peroxidation of methyl linoleate (ML) in Triton micelles was used as a kinetic testing model. The studied QH(2) were lipophilic triphenylphosphonium cations conjugated by an aliphatic linker to an antioxidant, i.e. a ubiquinol moiety (MitoQH(2)) or plastoquinol moiety (SkQH(2)). The antioxidant activity was characterized by the rate constant k(1) for the reaction between QH(2) and the lipid peroxyl radical (LO(2) (.)) originated from ML: QH(2) + LO(2) (.) --> HQ(.) + LOOH. All the tested QH(2) displayed a pronounced antioxidant activity. The oxidized forms of the same compounds did not inhibit ML peroxidation. The value of k(1) for SkQH(2) far exceeded k(1) for MitoQH(2). For the biologically active geroprotectors SkQ1H(2), the k(1) value found to be as high as 2.2 x 10(5) M(-) (1)s(-) (1), whereas for MitoQH(2), it was 0.58 x 10(5) M(-) (1)s(-) (1). The kinetic behavior of QH(2) suggested that SkQ1H(2) can rather easily diffuse through lipid-water microheterogeneous systems.

Entities:  

Keywords:  Geroprotector; antioxidant activity; mitochondria-targeted antioxidants; plastoquinone; triphenylphosphonium; ubiquinone

Mesh:

Substances:

Year:  2009        PMID: 20195487      PMCID: PMC2830047          DOI: 10.18632/aging.100049

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


Introduction

The oxidative stress caused by reactive oxygen species (ROS) is assumed to significantly contribute to aging and numerous age-related pathologies. Mitochondria are known as a place, where the most intensive ROS production can occur. In the recent years, mitochondria-targeted antioxidants has been developed [1-4]. Research was the series of papers published by our group in 1969-1970, where mitochondria-addressed penetrating synthetic cations were described and the idea to use these cations as "electric locomotives" targeting non-charged compounds to mitochondria was put forward [5,6]. In the late nineties, Murphy and coworkers initiated the practical realization of this idea [1,7-9]. They synthesized and tested several mitochondria-targeted antioxidants conjugated to the lipophilic alkyltriphenylphosphonium cations. The ubiquinone moiety linked to triphenylphosphonium cation by C10 aliphatic chain, MitoQ (Figure 1), seemed to be the most promising [1,4,9].
Figure 1.

The structure of the mitochondria-targeted hydroquinones and other phenolics studied in this work.

In 2005, an attempt was undertaken in our group to replace the ubiquinone moiety in MitoQ by plasto-quinone. As a result, a series of mitochondria-targeted antioxidants named SkQ has been synthesized [2,10]. There were two main reasons for this modification [1]. Plastoquinone playing in chloroplasts the same role of an electron carrier as ubiquinone does in mitochondria always operates under conditions of oxidative stress (elevated oxygen concentration and an intensive ROS production) [2]. It was reported [11-13] that the reactivity of the "tailless" plastoquinol analogs to the peroxyl radicals was indeed higher than that of natural ubiquinols. The advantage of mitochondria-targeted quinones of SkQ type over MitoQ was recently demonstrated by using several biological models. In particular, it was found that very low doses of SkQ1 (nmol/kg per day) prolong life of podospora, ceriodaphnia, drosophila and mice. In mice, SkQ1 doubled median lifespan arrested development of such traits of the senescence process as involution of thymus and decline of other immunity mechanisms; osteoporosis; disappearance of regular estrous cycles in females, cataract, retinopathies, balding, catinies, hypothermia, chromosome aberrations, peroxidation of lipids and proteins, etc. [10,14-20]. The structure of the mitochondria-targeted hydroquinones and other phenolics studied in this work. Until recently, the reactivity of the mitochondria-targeted antioxidants has, in fact, not been quantitatively determined. This was done in the present paper. The structure of the compounds studied is presented in Figure 1. The chain-breaking antioxidant activity was characterized by the rate constant for reaction of QH2 with the lipid peroxyl radical, LO2•, formed from ML or cardiolipin: LO2• + QH2¾→ LOOH + QH• k1 [1] which competes with the reaction of chain propagation of lipid peroxidation LO2• + LH (+O2) ¾→ LOOH + LO2• k2[2].

Results

Figure 2 shows that SkQ1 is almost completely reduced to SkQ1H2 by NaBH4. For SkQ1, the m/z value was found to be 537.08, which corresponds to the theoretically calculated one. As expected, the m/z value for SkQ1H2 proved to be 539.1, i.e. m/z increased by two units as compared with that for SkQ1. Similar results were also obtained for the reduction of other mitochondria-targeted quinones.
Figure 2.

The reduction of SkQ1 by NaBH4 as studied by UPLC-MS-MS analysis. (A) - Reverse-phase HPLC chromatograms before and after the addition of NaBH4. (B) - MS/MS spectra of SkQ1 before reduction (at the bottom) and after reduction (at the top). Details of the protocol are given in the text.

The reduction of SkQ1 by NaBH4 as studied by UPLC-MS-MS analysis. (A) - Reverse-phase HPLC chromatograms before and after the addition of NaBH4. (B) - MS/MS spectra of SkQ1 before reduction (at the bottom) and after reduction (at the top). Details of the protocol are given in the text. The non-inhibited oxidation of ML in Triton micelles is a chain process, which rate, R0, was found to be proportional to [ML] and square root of [AAPH] (not shown) as it was reported in our preceding papers [21,22]. Such relationships are also inherent in the lipid peroxidation in other aqueous microheterogeneous systems [23-25]. They correspond to the "classic" kinetic scheme with bimolecular chain termination [26,27]. AAPH + LH + (O2) ¾→ LO2• + products RIN (0) LO2• + LH + ¾→ LOOH + L• k2 [2] L• + O2¾→ LO2• k3 [3] LO2• + LO2•¾→ products 2k4 [4] All the tested QH2 displayed a pronounced chain-breaking antioxidant activity as this is exemplified by Figure 3 for SkQ1H2. When SkQ1H2 was added, the rate of oxidation, R, dramatically decreased. As SkQ1H2 was progressively consumed due to reaction [1], R increased with time and eventually reaches the level of non-inhibited oxidation. As a result, the pronounced induction period was observed (Figure 3A).
Figure 3.

The effect of 5 μM SkQ1H2 on the kinetics of oxygen consumption caused by oxidation of 20 mM ML in micellar solution of 50 mM Triton X-100 in 50mM phosphate buffer, pH 7.4, 37 °C. Oxidation was initiated by 3 mM AAPH. (A) [O2] trace; arrow shows addition of SkQ1H2. (B) plot A in the axes of Eq. 7.

The effect of 5 μM SkQ1H2 on the kinetics of oxygen consumption caused by oxidation of 20 mM ML in micellar solution of 50 mM Triton X-100 in 50mM phosphate buffer, pH 7.4, 37 °C. Oxidation was initiated by 3 mM AAPH. (A) [O2] trace; arrow shows addition of SkQ1H2. (B) plot A in the axes of Eq. 7. Quantitatively similar [O2] traces were observed with all the other tested QH2 as well as with α-tocopherol and its synthetic analog 6-hydroxy-2,2,5,7,8-pentamethylchromane (HPMC). As for C12TPP, a compound that has no hydroquinone moiety (Figure 1), it did not display any inhibiting activity (not shown). Meanwhile, oxidized form of SkQ1 showed a weak inhibition of ML oxidation, but only during a very short period of time (Figure 4). Most likely, the inhibition is caused in this case by a minor contamination of SkQ1H2 to SkQ1. A similar effect was also observed with other mitochondria-targeted Q. This suggests that mitochondria-targeted quinones by themselves do not act as a chain-breaking antioxidant.
Figure 4.

The effect of addition of 10 μM SkQ1 on the kinetics of oxygen consumption during the oxidation of 20 mM ML in 50 mM micellar solution of 50 mM Triton X-100 in 50mM phosphate buffer, pH 7.40, 37 °C, initiated by 3 mM AAPH. Arrow shows the moment when SkQ1 was added.

The effect of addition of 10 μM SkQ1 on the kinetics of oxygen consumption during the oxidation of 20 mM ML in 50 mM micellar solution of 50 mM Triton X-100 in 50mM phosphate buffer, pH 7.40, 37 °C, initiated by 3 mM AAPH. Arrow shows the moment when SkQ1 was added. The reduced forms of mitochondria-targeted quinones studied in this work are p-hydroquinones. Acting as chain-breaking antioxidants during the chain peroxidation of styrene p-hydroquinones, "tailless" analogs of mitochondria-targeted antioxidants show a very high inhibiting activity [11], sometimes comparable with that of α-tocopherol (k1 = 3.3 × 106M-1s-1 [26]). For instance, k1 for Me3BQH2 was found to be as much as 2.2 × 106M-1s-1 (Table 1). The behavior of p-hydroquinones in such a system does not differ from that of monophenolic antioxidants [26,27]. The situation dramatically changes when going to the peroxidation of ML in aqueous micelles [12,28]. The matter is that p-hydroxy-substituted phenoxyl radicals QH• formed in reaction [1] having, as a rule, pK less than 5 [29] undergo fast deprotonation at neutral pH: QH•¾→ Q•- + H+ [5] with the formation of semiquinone anion, Q•-, which reacts readily with molecular oxygen, forming O2•- [30,31]: Q•- + O2¾→ Q + O2•- [6] In turn, O2•- may react with oxidation substrate and QH2, most likely in its protonated form, HO2•. Both reactions result in a decrease in the inhibitory activity of QH2 [28]. SOD removes O2•-and thus arrests the mentioned undesirable reactions with the participation of O2•- (HO2•). This was a reason why SOD was always added to our system.
Table 1.

Kinetic parameters characterizing the antioxidant activity of the reduced forms of mitochondria-targeted quinones and their analogs in micellar solution of 50 mM Triton X-100, 50 mM phosphate buffer, pH 7.4, at 37 °C. Oxidation of ML or cardiolipin was initiated by AAPH. Notes: nd - not determined; a structures of QH2 are given in Figure 1; b figures in brackets are the number of independent experiments; c ML is replaced by cardiolipin; d determined during styrene oxidation in the bulk.

QH2 a k1/k2 b k1 × 105, M-1s-1
SkQ1H2 3670 ± 280 (7) 1980 ± 170 (3)c 2.2 ± 0.2 nd
SkQ3H2 2720 ± 210 (4) 1.6 ± 0.1
SkQ5H2 2670 ± 180 (5) 1.6 ± 0.1
MitoQH2 970 ± 55 (6) 520 ± 37 (3)c 0.58 ± 0.03 nd
DMQH2 1260 ± 85 (4) 0.76 ± 0.5
Me3BQH2 2170 ± 130 (4) 1.3 ± 0.1 23d
Me4BQH2 5020 ± 380 (3) 3.0 ± 0.2
Ubiquinol-0 700 ± 45 (3) 0.42 ± 0.03 4.4d
α-tocopherol 1170 ± 70 (4) 0.70 ± 0.04
HPMC 8680 ± 700 (4) 5.2 ± 0.4
Kinetic parameters characterizing the antioxidant activity of the reduced forms of mitochondria-targeted quinones and their analogs in micellar solution of 50 mM Triton X-100, 50 mM phosphate buffer, pH 7.4, at 37 °C. Oxidation of ML or cardiolipin was initiated by AAPH. Notes: nd - not determined; a structures of QH2 are given in Figure 1; b figures in brackets are the number of independent experiments; c ML is replaced by cardiolipin; d determined during styrene oxidation in the bulk. The [O2] traces recorded during the induction period of the inhibited oxidation of ML were used to determine k1. On the base of a reductive kinetic scheme, which includes reactions (0), [1], [2], and [4], the following equation can be deduced [11,12] where [LH] is the concentration of the oxidation substrate (in our case ML). Figure 3B depicts the original [O2] trace (Figure 3A) in the axes of Eq. [7]. It is seen that the plot of F vs. time is a straight line as predicted by Eq. [7]. The kinetic behavior of all the other QH2 studied proved to be was similar. The value of k1/k2 can be calculated from the slope of this straight line by using Eq. 7. It should be noted that this way of calculation of k1/k2 does not require the knowledge in RIN and the starting concentration of QH2. The values of k1/k2 are listed in Table 1. The absolute values of k1were calculated from k1/k2 assuming k2 = 60 M-1s-1 [22]. The k1 values are also listed in Table 1. With two QH2, SkQ1H2 and MitoQH2, similar experiments were conducted by using the same testing system, but with substituting ML by cardiolipin, the most oxidizable phospholipid component in mitochondria membranes [32,33]. As seen from Figure 5, both [O2] traces during the induction period of the inhibited oxidation and the plots of F vs. time are very similar to those for ML. The value of k1/k2 was calculated from the slope of the plot B (Figure 5) by using Eq. [7] assuming that each molecule of cardiolipin contains four fatty acid residue with 87 % linoleate in the cardiolipin sample used in this work (see http://www.avantilipids.com). These data are also presented in Table 1. Unfortunately, the absolute values of k1 could not be calculated, as k2 for the oxidation of cardiolipin has never been reported.
Figure 5.

The effect of addition of 10 μM SkQ1H2 on the kinetics of oxygen consumption during the oxidation of 2.6 mg mL-1 cardiolipin 50 mM micellar solution of 50 mM Triton X-100 in 50mM phosphate buffer, pH 7.40, 37 °C, initiated by 3 mM AAPH. Arrow shows the moment when SkQ1H2 was added.

The effect of addition of 10 μM SkQ1H2 on the kinetics of oxygen consumption during the oxidation of 2.6 mg mL-1 cardiolipin 50 mM micellar solution of 50 mM Triton X-100 in 50mM phosphate buffer, pH 7.40, 37 °C, initiated by 3 mM AAPH. Arrow shows the moment when SkQ1H2 was added.

Discussion

In this paper, the reactivity of the reduced forms of the mitochondria-targeted quinones as chain-breaking anti-oxidants has systematically been studied. As may be seen from Table 1, the k1 value for SkQ1H2, SkQ3H2 and SkQ5H2 are significantly higher than that for MitoQH2. This is in line with the data for simple "tailless" analogs of SkQ1H2 and MitoQH2, namely Me3BQH2, Me4BQH2 and Ubiquinol-0. The same tendency was earlier observed when effects of "tailless" analogues on the chain oxidation of styrene in bulk [11] and ML peroxidation in SDS micelles were studied [12]. Possible reasons why methyl-substituted p-hydroquinones are better antioxidants than methoxy-substituted p-hydroquinones were described elsewhere [11,26]. In brief, the effect under consideration is, the most probably, stereoelectronic by its nature. The matter is that o-methoxy group forms H-bond with oxygen belonging to the adjacent OH group. This causes the decrease in overlap between p-type orbital of oxygen atom of OH-group and the aromatic π-electron cloud (the increase of the dihedral angle between the aromatic ring and O - H bond). The latter results in strengthening O - H bond as compared with that in o-methyl substituted QH2, where such an intramolecular H-bond is absent. Among mitochondria-targeted QH2 studied in this work, SkQ1H2 showed the highest reactivity towards the lipid peroxyl radicals (Table 1). This observation is in line with data obtained in our group by using several biological models [2,10,14]. However, we recognize that the highest value of k1 for SkQ1H2 is likely not the only reason for the outstanding biological activity of SkQ1. It should be taken into account that k1 given in Table 1 are effective values and cannot be directly attributed to the elementary reaction [1]. The genuine values of k1 can be determined during the chain oxidation in non-polar media, for instance in styrene [11,34,35]. When going to the oxidation of fatty acid (ester) in bulk [12,36]and further to the oxidation in aqueous micelles and liposomes [12,26,37], the experimentally determined k1 values significantly decrease, nearly by one order of magnitude (see data for ubiquinol-0, Table 1). A reason for such a reduction of k1 was repeatedly discussed. The mentioned decrease in k1 is not specific of QH2. A similar effect has earlier been also reported for the oxidation inhibited by monophenolics [25,26,37,38]. The formation of H-bonds between the OH-group of phenolics and the carboxy-group of ML has been suggested as the main reason for the k1 decrease when going from the oxidation of non-polar hydrocarbon to that of fatty acid (ester) [36]. Recently, hydrogen bonding between phenols and fatty acid esters was directly observed by using the NMR technique [39]. Most likely, this is also true for QH2 studied in this work. The further decrease in k1 when going from ML oxidation in bulk to that in aqueous micelles may be explained by the additional formation of H-bonds between QH2 and water molecules as this was earlier suggested for monophenolics [23,37,38]. A general specific feature of reduced forms of the studied mitochondria-targeted quinoles is that their reactivity is actually very close to that of their "tailless" analogs (Table 1). This is in contrast to the couple "α-tocopherol having the long aliphatic chain its "tailless" analog HPMC. The k1 value for α-tocopherol is nearly one order of magnitude lower than that for HPMC (Table 1). This effect was reported to be even more pronounced in the SDS micelles [23,37,38]. The essential feature of our testing system and related microheterogeneous systems is that the concentration of the antioxidants tested is much lower than that of the oxidation substrate (in our case ML). While every micelle (microreactor) contains several molecules of ML, only a few micelles contain an antioxidant. Under these conditions, a fast LO2• reduction by an antioxidant is possible only if an antioxidant is capable of fast transferring from one microreactor to another, the characteristic time of this transfer being shorter than the time of the occurrence of a single kinetic chain. The antioxidants with a rather long aliphatic residue like α-tocopherol commonly do not meet such a requirement [37]. The fact that the values of k1 for the mitochondria-targeted quinols actually do not differ from that of their "tailless" analogs (Table 1) means that all of them are capable of the fast transfer from one microreactor to another. This is in line with a high reported ability of SkQ and MitoQ to easily penetrate through biological membranes [14].

Materials and methods

Methyl linoleate and Triton X-100 were purchased from Sigma, heart bovine cardiolipin disodium salt was received from Avanti PolarLipids. The water-soluble initiator 2,2'-azobis(2-amidinopropan) dihydrochloride (AAPH) was obtained from Polysciences. NaH2PO4 and Na2HPO4 of the highest quality used to prepare buffer solutions were purchased from Merck. The mitochondria-targeted quinones, SkQ1, SkQ3, SkQ5, MitoQ, DMQ as well as C12TPP (see Figure 1) were synthesized in the Mitoengineering Centre of Moscow State University [2]. Trimethylhydroquinone (Me3BQH2) was purchased from Aldrich; 2,3-dimethoxy-5-methyl-benzoqyuinone (ubiquinone-0) was from Sigma; tetramethylbenzoquinone (Me4BQ) was from EGA Chemie. All the other chemicals were of highest available quality. The reduced forms of the mitochondria-targeted quinones (QH2) were produced by the reduction of corresponding quinones by NaBH4 in the mixture of 50 mM NaH2PO4 (pH 5.0) with ethanol. This process was under control of UPLC-MS-MS (see below). Reduced forms of ubiquinone-0 and tetramethylhydroquinone (Me4BQH2) were produced by reduction of the quinones by Zn powder [21]. The buffer solution (pH 7.40 ± 0.02) was prepared by mixing 50 mM solutions of NaH2PO4 and Na2HPO4. In turn, the solutions of the individual sodium phosphates were prepared with doubly distilled water and were purged from traces of transition metals by Chelex-100 resin (Bio-Rad). HPLC-diode array detection-electrospray ionization tandem mass spectrometry analysis (UPLC-MS-MS) was performed using an ACQUITY system (Waters, Milford, MA, USA). Chromatography was carried out using an ACQUITY BEH C18 column (2.1 x 50 mm, 1.7 μm) eluted with a gradient of 40-60% acetonitrile (4 min) and 20 mM acetic acid (pH 3.0) delivered at a flow rate of 0.5 mL per min. UV-monitoring was performed at 280 mm. An injection volume of 11.2 μL (full loop) was used in all cases. A Quattro triple-quadrupole mass spectrometer (Micromass-Waters) fitted with a Z-Spray ion interface was used for analyses. Ionization was achieved using electrospray in a positive ionization mode. The following conditions were found to be optimal for the analysis of SkQ1: capillary voltage, 3.0 kV; source block temperature, 120°C; and desolvatation gas (nitrogen) heated to 450°C and delivered at a flow rate of 800 L h-1; cone voltage, 55 V; cone Gas Flow rate, 50 L h-1. MassLynx 4.0 software (Waters) was used for processing. The standard testing system was composed of 50 mM buffer, pH 7.4, 50 mM Triton X-100, 2-4 mM AAPH, 8-20 mM ML and 20 unit mL-1 SOD. In some experiments, ML was replaced by cardiolipin. The kinetics of oxygen consumption accompanied ML (cardiolipin) oxidation were studied with a computerized 5300 Biological Oxygen Monitor (Yellow Springs Instruments Co., USA) with a Clark electrode as a sensor. The rate of oxidation was measured as a slope of [O2] traces. Experiments were conducted at 37.0 ± 0.1 °C. ML was added to preliminarily thermostated micellar solution of Triton X-100 and AAPH in buffer. Monitoring was started 3-5 min after ML addition and the rate of non-inhibited oxidation (R0) was measured. The tested compounds were then added to a reaction chamber under steady monitoring as a stock solution by using a Hamilton micro-syringe. In more detail, the protocol was described elsewhere [12,21,22].
  25 in total

1.  Interrelations of mitochondrial fragmentation and cell death under ischemia/reoxygenation and UV-irradiation: protective effects of SkQ1, lithium ions and insulin.

Authors:  E Y Plotnikov; A K Vasileva; A A Arkhangelskaya; I B Pevzner; V P Skulachev; D B Zorov
Journal:  FEBS Lett       Date:  2008-08-12       Impact factor: 4.124

2.  Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 5. SkQ1 prolongs lifespan and prevents development of traits of senescence.

Authors:  V N Anisimov; L E Bakeeva; P A Egormin; O F Filenko; E F Isakova; V N Manskikh; V M Mikhelson; A A Panteleeva; E G Pasyukova; D I Pilipenko; T S Piskunova; I G Popovich; N V Roshchina; O Yu Rybina; V B Saprunova; T A Samoylova; A V Semenchenko; M V Skulachev; I M Spivak; E A Tsybul'ko; M L Tyndyk; M Yu Vyssokikh; M N Yurova; M A Zabezhinsky; V P Skulachev
Journal:  Biochemistry (Mosc)       Date:  2008-12       Impact factor: 2.487

3.  Cardiolipin as an oxidative target in cardiac mitochondria in the aged rat.

Authors:  Edward J Lesnefsky; Charles L Hoppel
Journal:  Biochim Biophys Acta       Date:  2008-06-02

Review 4.  Selective targeting of bioactive compounds to mitochondria.

Authors:  M P Murphy
Journal:  Trends Biotechnol       Date:  1997-08       Impact factor: 19.536

Review 5.  Drug delivery to mitochondria: the key to mitochondrial medicine.

Authors:  M P Murphy; R A Smith
Journal:  Adv Drug Deliv Rev       Date:  2000-03-30       Impact factor: 15.470

Review 6.  Mitochondria, oxidative stress and cell death.

Authors:  Martin Ott; Vladimir Gogvadze; Sten Orrenius; Boris Zhivotovsky
Journal:  Apoptosis       Date:  2007-05       Impact factor: 4.677

7.  Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 3. Inhibitory effect of SkQ1 on tumor development from p53-deficient cells.

Authors:  L S Agapova; B V Chernyak; L V Domnina; V B Dugina; A Yu Efimenko; E K Fetisova; O Yu Ivanova; N I Kalinina; N V Khromova; B P Kopnin; P B Kopnin; M V Korotetskaya; M R Lichinitser; A L Lukashev; O Yu Pletjushkina; E N Popova; M V Skulachev; G S Shagieva; E V Stepanova; E V Titova; V A Tkachuk; J M Vasiliev; V P Skulachev
Journal:  Biochemistry (Mosc)       Date:  2008-12       Impact factor: 2.487

8.  Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 4. Age-related eye disease. SkQ1 returns vision to blind animals.

Authors:  V V Neroev; M M Archipova; L E Bakeeva; A Zh Fursova; E N Grigorian; A Yu Grishanova; E N Iomdina; Zh N Ivashchenko; L A Katargina; I P Khoroshilova-Maslova; O V Kilina; N G Kolosova; E P Kopenkin; S S Korshunov; N A Kovaleva; Yu P Novikova; P P Philippov; D I Pilipenko; O V Robustova; V B Saprunova; I I Senin; M V Skulachev; L F Sotnikova; N A Stefanova; N K Tikhomirova; I V Tsapenko; A I Shchipanova; R A Zinovkin; V P Skulachev
Journal:  Biochemistry (Mosc)       Date:  2008-12       Impact factor: 2.487

9.  Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 1. Cationic plastoquinone derivatives: synthesis and in vitro studies.

Authors:  Y N Antonenko; A V Avetisyan; L E Bakeeva; B V Chernyak; V A Chertkov; L V Domnina; O Yu Ivanova; D S Izyumov; L S Khailova; S S Klishin; G A Korshunova; K G Lyamzaev; M S Muntyan; O K Nepryakhina; A A Pashkovskaya; O Yu Pletjushkina; A V Pustovidko; V A Roginsky; T I Rokitskaya; E K Ruuge; V B Saprunova; I I Severina; R A Simonyan; I V Skulachev; M V Skulachev; N V Sumbatyan; I V Sviryaeva; V N Tashlitsky; J M Vassiliev; M Yu Vyssokikh; L S Yaguzhinsky; A A Zamyatnin; V P Skulachev
Journal:  Biochemistry (Mosc)       Date:  2008-12       Impact factor: 2.487

Review 10.  Targeting mitochondria.

Authors:  Adam T Hoye; Jennifer E Davoren; Peter Wipf; Mitchell P Fink; Valerian E Kagan
Journal:  Acc Chem Res       Date:  2008-01       Impact factor: 22.384

View more
  9 in total

1.  Boosting antioxidants by lipophilization: a strategy to increase cell uptake and target mitochondria.

Authors:  Christelle Bayrasy; Béatrice Chabi; Mickaël Laguerre; Jérôme Lecomte; Elodie Jublanc; Pierre Villeneuve; Chantal Wrutniak-Cabello; Gérard Cabello
Journal:  Pharm Res       Date:  2013-04-19       Impact factor: 4.200

Review 2.  Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.

Authors:  Jacek Zielonka; Joy Joseph; Adam Sikora; Micael Hardy; Olivier Ouari; Jeannette Vasquez-Vivar; Gang Cheng; Marcos Lopez; Balaraman Kalyanaraman
Journal:  Chem Rev       Date:  2017-06-27       Impact factor: 60.622

Review 3.  Besides Huntington's disease, does brain-type creatine kinase play a role in other forms of hearing impairment resulting from a common pathological cause?

Authors:  Yow-Sien Lin; Chin-Hung Wang; Yijuang Chern
Journal:  Aging (Albany NY)       Date:  2011-06       Impact factor: 5.682

4.  A mitochondrially targeted compound delays aging in yeast through a mechanism linking mitochondrial membrane lipid metabolism to mitochondrial redox biology.

Authors:  Michelle T Burstein; Vladimir I Titorenko
Journal:  Redox Biol       Date:  2014-01-23       Impact factor: 11.799

5.  Role of mitochondrial reactive oxygen species in age-related inflammatory activation of endothelium.

Authors:  Roman A Zinovkin; Valeria P Romaschenko; Ivan I Galkin; Vlada V Zakharova; Olga Yu Pletjushkina; Boris V Chernyak; Ekaterina N Popova
Journal:  Aging (Albany NY)       Date:  2014-08       Impact factor: 5.682

Review 6.  Current experience in testing mitochondrial nutrients in disorders featuring oxidative stress and mitochondrial dysfunction: rational design of chemoprevention trials.

Authors:  Giovanni Pagano; Annarita Aiello Talamanca; Giuseppe Castello; Mario D Cordero; Marco d'Ischia; Maria Nicola Gadaleta; Federico V Pallardó; Sandra Petrović; Luca Tiano; Adriana Zatterale
Journal:  Int J Mol Sci       Date:  2014-11-05       Impact factor: 5.923

Review 7.  Generation of reactive oxygen species in the anterior eye segment. Synergistic codrugs of N-acetylcarnosine lubricant eye drops and mitochondria-targeted antioxidant act as a powerful therapeutic platform for the treatment of cataracts and primary open-angle glaucoma.

Authors:  Mark A Babizhayev
Journal:  BBA Clin       Date:  2016-04-19

8.  Mitochondrial membrane lipidome defines yeast longevity.

Authors:  Adam Beach; Vincent R Richard; Anna Leonov; Michelle T Burstein; Simon D Bourque; Olivia Koupaki; Mylène Juneau; Rachel Feldman; Tatiana Iouk; Vladimir I Titorenko
Journal:  Aging (Albany NY)       Date:  2013-07       Impact factor: 5.682

Review 9.  Mitochondrial dysfunction in obesity: potential benefit and mechanism of Co-enzyme Q10 supplementation in metabolic syndrome.

Authors:  Md Ashraful Alam; Md Mahbubur Rahman
Journal:  J Diabetes Metab Disord       Date:  2014-05-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.